Squarepoint’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,950
| Closed | -$134K | – | 3367 |
|
|
2024
Q4 | $134K | Sell |
13,950
-98,315
| -88% | -$944K | ﹤0.01% | 2486 |
|
|
2024
Q3 | $321K | Buy |
112,265
+29,628
| +36% | +$84.7K | ﹤0.01% | 1965 |
|
|
2024
Q2 | $241K | Buy |
+82,637
| New | +$241K | ﹤0.01% | 2063 |
|
|
2023
Q4 | – | Sell |
-222,315
| Closed | -$529K | – | 3064 |
|
|
2023
Q3 | $529K | Sell |
222,315
-7,685
| -3% | -$18.3K | ﹤0.01% | 1608 |
|
|
2023
Q2 | $405K | Buy |
230,000
+58,155
| +34% | +$102K | ﹤0.01% | 1709 |
|
|
2023
Q1 | $529K | Buy |
+171,845
| New | +$529K | ﹤0.01% | 1439 |
|
|
2021
Q1 | – | Sell |
-12,234
| Closed | -$134K | – | 3142 |
|
|
2020
Q4 | $134K | Buy |
12,234
+969
| +9% | +$10.6K | ﹤0.01% | 2269 |
|
|
2020
Q3 | $100K | Buy |
+11,265
| New | +$100K | ﹤0.01% | 2126 |
|